CA1133214A - Disposable face mask - Google Patents
Disposable face maskInfo
- Publication number
- CA1133214A CA1133214A CA340,865A CA340865A CA1133214A CA 1133214 A CA1133214 A CA 1133214A CA 340865 A CA340865 A CA 340865A CA 1133214 A CA1133214 A CA 1133214A
- Authority
- CA
- Canada
- Prior art keywords
- cushion
- compound
- mold
- patient
- mask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- 238000000465 moulding Methods 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000004604 Blowing Agent Substances 0.000 claims abstract description 16
- 238000001746 injection moulding Methods 0.000 claims abstract description 10
- 238000002347 injection Methods 0.000 claims abstract description 8
- 239000007924 injection Substances 0.000 claims abstract description 8
- 238000013022 venting Methods 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000004800 polyvinyl chloride Substances 0.000 claims description 9
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 2
- 239000004156 Azodicarbonamide Substances 0.000 claims 1
- XOZUGNYVDXMRKW-AATRIKPKSA-N azodicarbonamide Chemical compound NC(=O)\N=N\C(N)=O XOZUGNYVDXMRKW-AATRIKPKSA-N 0.000 claims 1
- 235000019399 azodicarbonamide Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 239000011369 resultant mixture Substances 0.000 claims 1
- 238000007711 solidification Methods 0.000 claims 1
- 230000008023 solidification Effects 0.000 claims 1
- 239000007789 gas Substances 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 abstract description 5
- 210000003850 cellular structure Anatomy 0.000 abstract description 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- 229920001169 thermoplastic Polymers 0.000 abstract description 3
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000019589 hardness Nutrition 0.000 abstract 1
- 239000006260 foam Substances 0.000 description 12
- 230000001815 facial effect Effects 0.000 description 6
- 229940090044 injection Drugs 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000002666 chemical blowing agent Substances 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012815 thermoplastic material Substances 0.000 description 2
- 238000009757 thermoplastic moulding Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/34—Auxiliary operations
- B29C44/36—Feeding the material to be shaped
- B29C44/38—Feeding the material to be shaped into a closed space, i.e. to make articles of definite length
- B29C44/42—Feeding the material to be shaped into a closed space, i.e. to make articles of definite length using pressure difference, e.g. by injection or by vacuum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/14—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor incorporating preformed parts or layers, e.g. injection moulding around inserts or for coating articles
- B29C45/14336—Coating a portion of the article, e.g. the edge of the article
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/48—Wearing apparel
- B29L2031/4807—Headwear
- B29L2031/4835—Masks
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Injection Moulding Of Plastics Or The Like (AREA)
Abstract
ABSTRACT
A method for forming a disposable face mask for medical purposes to carry out the administration of gases to a patient is disclosed and which provides a relatively soft, pliant surface that readily conforms to the patient's anatomical features in a gas-tight fit. The mask, as formed, comprises two parts; a semi-rigid cone backing to which there is affixed a cushion formed in accordance with this invention. The cushion is produced by in-jection molding a thermoplastic compound of a predetermined hard-ness. The thermoplastic compound is first combined with a blow-ing agent, and the mixed compound heated to break down the blow-ing agent to give off a gas, such as nitrogen. The heated, plasticized material is then injection molded into a mold of the desired configuration. The molding conditions, such as the vent-ing thereof, are controlled to cause formation of a small, rela-tively uniform cellular structure within the body of the finished product cushion. The control of the conditions involved in the injection molding process enables the final cell structure to be uniform and made up of cells which exhibit excellent pliant characteristics for conforming to the anatomical features of a patient.
A method for forming a disposable face mask for medical purposes to carry out the administration of gases to a patient is disclosed and which provides a relatively soft, pliant surface that readily conforms to the patient's anatomical features in a gas-tight fit. The mask, as formed, comprises two parts; a semi-rigid cone backing to which there is affixed a cushion formed in accordance with this invention. The cushion is produced by in-jection molding a thermoplastic compound of a predetermined hard-ness. The thermoplastic compound is first combined with a blow-ing agent, and the mixed compound heated to break down the blow-ing agent to give off a gas, such as nitrogen. The heated, plasticized material is then injection molded into a mold of the desired configuration. The molding conditions, such as the vent-ing thereof, are controlled to cause formation of a small, rela-tively uniform cellular structure within the body of the finished product cushion. The control of the conditions involved in the injection molding process enables the final cell structure to be uniform and made up of cells which exhibit excellent pliant characteristics for conforming to the anatomical features of a patient.
Description
3Zi~
Back~round of the Invention Basically, face masks are used for many different purposes in administering gases to a patient. Typically, such purposes include the administration of inhalant anesthetics to patients for anesthetizing the same during surgical procedures.
Face masks are also included as part of a patient breathing circuit wherein the inhalation of air or oxygen enriched air is assisted by the development of positive pressure within the breathing circuit.
The mask characteristics must be such as to be easily and comfortably conformed to the patient's facial anatomical features despite the obvious unlimited variety of such features.
Normally, such masks must provide a relatively gas-tight fit against the face of the patient to prevent escape of gases to the atmosphere that are intended for the patient, yet it is ad-vantageous that such seal be obtained with a minimum of pressure against the patient, to minimize facial trauma.
Many masks presently on the market are also readily disposable, that is, they are produced and marketed at a price that makes it advantageous for the hospital, or other user, to discard the mask after each use, rather than attempt to clean or sterilize the mask for use on subsequent patients. Disposabil-ity, of course, completely alleviates the risk of cross-infection between patients.
Mask producers, therefore, are faced with the produc-tion constraints that the eventual mask must be comfortable, pliable against the patient's face, and yet the production pro-cedures must be susceptible of inexpensive mass production capa-bilities to produce a mask competitive with other commercial dis-posable products.
Back~round of the Invention Basically, face masks are used for many different purposes in administering gases to a patient. Typically, such purposes include the administration of inhalant anesthetics to patients for anesthetizing the same during surgical procedures.
Face masks are also included as part of a patient breathing circuit wherein the inhalation of air or oxygen enriched air is assisted by the development of positive pressure within the breathing circuit.
The mask characteristics must be such as to be easily and comfortably conformed to the patient's facial anatomical features despite the obvious unlimited variety of such features.
Normally, such masks must provide a relatively gas-tight fit against the face of the patient to prevent escape of gases to the atmosphere that are intended for the patient, yet it is ad-vantageous that such seal be obtained with a minimum of pressure against the patient, to minimize facial trauma.
Many masks presently on the market are also readily disposable, that is, they are produced and marketed at a price that makes it advantageous for the hospital, or other user, to discard the mask after each use, rather than attempt to clean or sterilize the mask for use on subsequent patients. Disposabil-ity, of course, completely alleviates the risk of cross-infection between patients.
Mask producers, therefore, are faced with the produc-tion constraints that the eventual mask must be comfortable, pliable against the patient's face, and yet the production pro-cedures must be susceptible of inexpensive mass production capa-bilities to produce a mask competitive with other commercial dis-posable products.
- 2 -Present commercial masks are formed by a variety of - methods. One type includes a cushion with a flexible flap which contacts the patient's face, having no sponge or foam character-istics. Another type is a single piece molded flexible mask, again having no viable cushion that conforms to the patient's face.
One further commercial type is produced by an in situ foaming, on a cone backing, of a polyurethane foam that forms a soft cushion. Other masks are believed made with a "foam" type cushion, however, such are made by cutting a foam to the desired size and bonding the same to a cone backing.
The present masks still have some undesirable features, however, either in the facial compliance or as to the manufac-turing procedures which are expensive. Specifically, flexible flaps and single piece masks do not comfortably comply to a patient's anatomical features even though they can be produced very inexpensively, while the present formed in situ masks do have good compliance characteristics but have certain disadvan-tages in the manufacturing thereof, they require manual trimming and involve the use of chemicals that are undesirable in the environmental surroundings.
Summary of the Invention This invention relates to a method of producing dis-posable face masks used in administering various gases to patients for medical treatment. More specifically, the present invention comprises a method of forming a mask cushion by injection mold-ing of such cushion through the use of a thermoplastic molding compound (also referred to as a "dry blend") in which there is combined a blowing agent. The injection molding is carried out ~133Z14 under certain predetermined conditions, such that the thus formed cushion exhibits soft, pliable characteristics that enable it to be easily fitted to the face of a patient and a relatively gas-tight fit is possible.
The present invention overcomes certain difficulties of the aforedescribed present commercial masks by providing a method whereby the foam cushion is injection molded, thus the formed cushion is of the desired dimensions and the labor time and cost of trimming, cutting and the like are significantly reduced.
Also, the finished foam characteristics are such that a cellular foam consistency is covered by a resilient skin and which is soft and pliable and thus readily conforms to the in-dividual features of the patient's face without excessive pres-sure thereagainst to effect an essentially gas-tight seal.
The overall process is readily adapted to high quanti-ty mass production with a mlnimum of hand operations but with good consistency of product.
The process achieves these advantages over the various prior art processes and masks made by using prior art processes by the combining of a thermoplastic compound with a blowing agent and heating the mixed compound prior to the injection mold-ing step. The heated, plasticized material, including the re-leased gas, is thereafter injection molded with a mold having the desired cushion dimensions and configuration. The foam cushion is thus formed in the mold by the released gas from the foaming agent, such that the controlled conditions bring about a particu-lar foam characteristic of relatively uniform cellular structure having small cells. A resilient skin is likewise formed about the cellular structure and, acting in conjunction with the cellu-1~33Zi4 lar foam, presents a soft pliable surface to the patient's face for conformance thereto in a gas-tight relationship.
The improved process for producing a molded face mask in accordance with the present invention is illustrated in the accompanying drawings, which show how the preferred embodiment - of the invention is carried out.
Brief Description of the Drawin~s ; FIG. 1 is a block diagram showing the sequential steps taken to produce a mixed molding compound used in the present invention; and FIG. 2 is a schematic view of an injection molding machine used to carry out the steps of forming the face mask of this invention; and FIG. 3 is an isometric view of a mask cushion formed in the machine of FIG. 2, using a molding compound produced in accordance with FIG. l; and FIG. 4 is an isometric view of a completed mask pro-vided in accordance with the process of the present invention.
Description of the Preferred Embodiment In Fig. 1 there is shown a block diagram of the sequen-tial steps taken to produce the molding composition used to pro-duce a mask in accordance with the present invention. A source 10 of suitable molding compound is provided for producing the desired composition. Preferably, the molding compound is a thermoplastic material, and the more preferred of such materials is polyvinyl chloride (PVC) having a hardness of about 38 duro-meter on the Shore A scale. Such grade is commercially available and the further description will refer to PVC as the molding ` `~
compound for convenience, although it will be recognized that other thermoplastic molding materials may be utilized.
A chemical blowing agent source 12 is also provided and which supplies a chemical blowing agent for mixing in pre-determined properties with the molding compound to produce a composition for use with this invention. A7.odicarbonamide is the most widely used chemical blowing agent. One such suitable chemical blowing agent is Kempor 200, sold commercially by Stepan Chemical Company and which gives off nitrogen and other gases under certain molding conditions. That particular blow-ing agent is available in powder form and, therefore, is very convenient for mixing with the molding compound which is also preferably in powder form. It is possible to utilize a blowing agent in the form of liquids, also commercially available, how-ever, it is considerably more difficult to obtain a suitable uniform mixture of the same with a molding compound in a powder form.
With the preferred ingredients, therefore, the PVC
molding compound powder is mixed with the blowing agent powder in a commercially available ribbon blender 14 in predetermined proportions, with standard grade PVC powder and the aforemen-tioned Kempor 200 blowing agent, a mixing ratio in the range of one part blowing agent to 99 parts molding compound is utilized and which produces excellent results, however, on a weight per-cent basis, adequate results have been achieved when the blowing agent percent ranges from about .25% to about 1.5% by weight.
The mixed compound, of uniform consistency and mixing, is desired from the ribbon mixer 14 as shown at 16. The mixed COmpOUn(] iS l-OW ready for usc witll an injcction moldillg m~chine in a manner to be described.
TRADEMARK
Turning now to Fig. 2, there is illustrated an injec-tion molding machine 18 in schematic form. The injection mold-ing machine 18 comprises a main barrel 20 in which is positioned a screw 22 which is adapted to rotate by means of motor 24. Mold-ing compound is gravity fed into the barrel 20 from hopper 26 where a supply of such compound is retained. In the present in-vention, of course, the molding compound is the mixed compound from 16 (Fig. 1). A plurality of heating zones 1-4 and numbered, respectively, 28, 30, 32 and 34, are positioned between that por-tion of the main barrel 20 receiving mixed compound from hopper26 and the nozzle 36 from which the mixed compound is ultimately injected into a mold 38. The mold 38 has a suitably shaped cavity 40 in the form of the mask cushion which is desired to be formed. The mold 38 varies, of course, in accordance with the particular mask cushion being produced, i.e. adult size, child-ren's size, etc. A shut-off valve 42 is also included at the end of the heating zones and prior to the injection of the mixed compound from nozzle 36.
At the opposite end of the barrel 20 from nozzle 36, there is located a hydraulic cylinder 44 which is adapted to move the screw 22 when activated, as will be later explained.
In the operation of the injection molding machine 18, the mixed compound in the hopper 26 provides a continuous feed of the same into the barrel 20. The heating zones are initially brought up to temperature in progressively higher temperature to heat the mixed compound as it progresses towards nozzle 36. With PVC compound and the preferred blowing agent, the heating zones may be set such that zones 28, 30, 32 and 34 are respectively at temperatures of about 260F, 260F, 320F and 350F. A typi-cal injection cycle, to be described, takes about 20 seconds and the temperature of the mold 38 is about 60F to about 120F, al-; though the mold temperature is not a particularly critical value.
The cycle is initiated as mold 38 is closed. The hy-draulic cylinder 44 thereupon moves the screw 22 forward toward mold 38. Screw 22 acts like a plunger and forces the mixed com-pound within barrel 20 toward the mold 38. The valve 42 opens and the heated mixed compound is thus forced into the mold cavity 40 into the configuration of a mask cushion.
At the end of the forward stroke of hydraulic cylinder 44 and screw 22, the shut-off valve 42 again closes and the screw 22 rotates to force additional mixed compound from the hopper 26 in the direction of the mold 38 within the barrcl 20. As the barrel 20 fills with mixed compound, the screw 22 rotates itself backwards and causes an internal backpressure on the mixed com-pound as the screw 22 moves back to its original position. The controlled backpressure exerted by the screw 22 on the mixed com-pound serves to pack the compound tightly and also serves to pre-vent the escaE)e of gas that is being released from the blowing agent backward toward hopper 26. At the end toward the mold 38, ~he valve 42 is, of course, now sllut so that no gas or plasti-cized material is lost or leaked into the mold 38.
As the mixed compound is compacted in the end of the barrel toward the mold 38, the compound passes through the heat-ing zones 28, 30, 32 and 34. As the mixed compound approaches the final heating zone 34, it becomes plasticized and the par-ticular blowing agent breaks down as a result of the pressure and temperature conditions and gives off a gas (in the case of the preferred blowing agent, that gas is nitrogen). The gas goes into solution with the plasticized material and remains in such form until the next injection step.
11~3Z~4 As the cycle is completed, the plasticized material that has been injected into the mold 38 cools, the mold 38 is opened and the thus formed mask cushion is removed.
The mold cavity 40 is vented to allow the escape of a predetermined amount of "freed" gas to achieve the desired mask cushion consistency. The amount of controlled venting determines the cellular size and therefore determines the pliability of the cushion. Too much venting results in coarse cell structure re-sulting in loss of pliability, while too little venting creates very fine, almost non-existent cell size, again resulting in an absence of pliability. The venting is determined by testing the particular mold cavity and setting and adjusting the amount of venting such that the desired cellular structure is achieved which exhibits soft pliable characteristics.
The resulting cushion 46 removed from the mold 38 is shown in Fig. 3. In the preferred form, the cushion 46 has a specific gravity of between about .5 to about .8 and with a base compound of 38 durometer (Shore A). The pliability exhibits adequate compressibility and is readily adapted to conform to the facial anatomical features of a patient.
The final patient mask 48, Fig. 4, is produced by af-fixing the foam cushion 46 to a cone 50. The cone 50 is formed by conventional methods, such as injection molding and is prefer-ably of a thermoplastic material such as PVC. The cone 50 may be opaque, transparent or translucent, depending upon the material used. Preferably the cone 50 is made of such a material 'PVC) such that the cone 50 may, if desired, be solvent bonded to the foam cushion 46. Alternatively, the cushion 46 and cone 50 may be affixed together by mechanical means or through bonding by means of a suitable adhesive, or by inserting the cone into the mold and molding the cushion to it ~insert molding).
g 11;~3Z14 Thus, there is produced a face mask having particular-ly advantageous softness characteristics by a judicious selec-tion of materials and conditions, such that a foam cushion is injection molded and which is affixed to a cone backing to pro-duce a face mask that is inexpensive to produce, yet which is easily adaptable to conform to the facial anatomical features of a patient. The cushion support is kept to a minimum through the cone backing and which allows its soft characteristic to be fully utilized in molding itself to the patient features with a minimum of pressure on the face mask, such as to reduce the pos-sibility of patient facial trauma.
It will be understood that the scope of the method and product of this invention is not limited to the particular steps or materials disclosed herein, by way of example, but only by the scope of the appended claims.
One further commercial type is produced by an in situ foaming, on a cone backing, of a polyurethane foam that forms a soft cushion. Other masks are believed made with a "foam" type cushion, however, such are made by cutting a foam to the desired size and bonding the same to a cone backing.
The present masks still have some undesirable features, however, either in the facial compliance or as to the manufac-turing procedures which are expensive. Specifically, flexible flaps and single piece masks do not comfortably comply to a patient's anatomical features even though they can be produced very inexpensively, while the present formed in situ masks do have good compliance characteristics but have certain disadvan-tages in the manufacturing thereof, they require manual trimming and involve the use of chemicals that are undesirable in the environmental surroundings.
Summary of the Invention This invention relates to a method of producing dis-posable face masks used in administering various gases to patients for medical treatment. More specifically, the present invention comprises a method of forming a mask cushion by injection mold-ing of such cushion through the use of a thermoplastic molding compound (also referred to as a "dry blend") in which there is combined a blowing agent. The injection molding is carried out ~133Z14 under certain predetermined conditions, such that the thus formed cushion exhibits soft, pliable characteristics that enable it to be easily fitted to the face of a patient and a relatively gas-tight fit is possible.
The present invention overcomes certain difficulties of the aforedescribed present commercial masks by providing a method whereby the foam cushion is injection molded, thus the formed cushion is of the desired dimensions and the labor time and cost of trimming, cutting and the like are significantly reduced.
Also, the finished foam characteristics are such that a cellular foam consistency is covered by a resilient skin and which is soft and pliable and thus readily conforms to the in-dividual features of the patient's face without excessive pres-sure thereagainst to effect an essentially gas-tight seal.
The overall process is readily adapted to high quanti-ty mass production with a mlnimum of hand operations but with good consistency of product.
The process achieves these advantages over the various prior art processes and masks made by using prior art processes by the combining of a thermoplastic compound with a blowing agent and heating the mixed compound prior to the injection mold-ing step. The heated, plasticized material, including the re-leased gas, is thereafter injection molded with a mold having the desired cushion dimensions and configuration. The foam cushion is thus formed in the mold by the released gas from the foaming agent, such that the controlled conditions bring about a particu-lar foam characteristic of relatively uniform cellular structure having small cells. A resilient skin is likewise formed about the cellular structure and, acting in conjunction with the cellu-1~33Zi4 lar foam, presents a soft pliable surface to the patient's face for conformance thereto in a gas-tight relationship.
The improved process for producing a molded face mask in accordance with the present invention is illustrated in the accompanying drawings, which show how the preferred embodiment - of the invention is carried out.
Brief Description of the Drawin~s ; FIG. 1 is a block diagram showing the sequential steps taken to produce a mixed molding compound used in the present invention; and FIG. 2 is a schematic view of an injection molding machine used to carry out the steps of forming the face mask of this invention; and FIG. 3 is an isometric view of a mask cushion formed in the machine of FIG. 2, using a molding compound produced in accordance with FIG. l; and FIG. 4 is an isometric view of a completed mask pro-vided in accordance with the process of the present invention.
Description of the Preferred Embodiment In Fig. 1 there is shown a block diagram of the sequen-tial steps taken to produce the molding composition used to pro-duce a mask in accordance with the present invention. A source 10 of suitable molding compound is provided for producing the desired composition. Preferably, the molding compound is a thermoplastic material, and the more preferred of such materials is polyvinyl chloride (PVC) having a hardness of about 38 duro-meter on the Shore A scale. Such grade is commercially available and the further description will refer to PVC as the molding ` `~
compound for convenience, although it will be recognized that other thermoplastic molding materials may be utilized.
A chemical blowing agent source 12 is also provided and which supplies a chemical blowing agent for mixing in pre-determined properties with the molding compound to produce a composition for use with this invention. A7.odicarbonamide is the most widely used chemical blowing agent. One such suitable chemical blowing agent is Kempor 200, sold commercially by Stepan Chemical Company and which gives off nitrogen and other gases under certain molding conditions. That particular blow-ing agent is available in powder form and, therefore, is very convenient for mixing with the molding compound which is also preferably in powder form. It is possible to utilize a blowing agent in the form of liquids, also commercially available, how-ever, it is considerably more difficult to obtain a suitable uniform mixture of the same with a molding compound in a powder form.
With the preferred ingredients, therefore, the PVC
molding compound powder is mixed with the blowing agent powder in a commercially available ribbon blender 14 in predetermined proportions, with standard grade PVC powder and the aforemen-tioned Kempor 200 blowing agent, a mixing ratio in the range of one part blowing agent to 99 parts molding compound is utilized and which produces excellent results, however, on a weight per-cent basis, adequate results have been achieved when the blowing agent percent ranges from about .25% to about 1.5% by weight.
The mixed compound, of uniform consistency and mixing, is desired from the ribbon mixer 14 as shown at 16. The mixed COmpOUn(] iS l-OW ready for usc witll an injcction moldillg m~chine in a manner to be described.
TRADEMARK
Turning now to Fig. 2, there is illustrated an injec-tion molding machine 18 in schematic form. The injection mold-ing machine 18 comprises a main barrel 20 in which is positioned a screw 22 which is adapted to rotate by means of motor 24. Mold-ing compound is gravity fed into the barrel 20 from hopper 26 where a supply of such compound is retained. In the present in-vention, of course, the molding compound is the mixed compound from 16 (Fig. 1). A plurality of heating zones 1-4 and numbered, respectively, 28, 30, 32 and 34, are positioned between that por-tion of the main barrel 20 receiving mixed compound from hopper26 and the nozzle 36 from which the mixed compound is ultimately injected into a mold 38. The mold 38 has a suitably shaped cavity 40 in the form of the mask cushion which is desired to be formed. The mold 38 varies, of course, in accordance with the particular mask cushion being produced, i.e. adult size, child-ren's size, etc. A shut-off valve 42 is also included at the end of the heating zones and prior to the injection of the mixed compound from nozzle 36.
At the opposite end of the barrel 20 from nozzle 36, there is located a hydraulic cylinder 44 which is adapted to move the screw 22 when activated, as will be later explained.
In the operation of the injection molding machine 18, the mixed compound in the hopper 26 provides a continuous feed of the same into the barrel 20. The heating zones are initially brought up to temperature in progressively higher temperature to heat the mixed compound as it progresses towards nozzle 36. With PVC compound and the preferred blowing agent, the heating zones may be set such that zones 28, 30, 32 and 34 are respectively at temperatures of about 260F, 260F, 320F and 350F. A typi-cal injection cycle, to be described, takes about 20 seconds and the temperature of the mold 38 is about 60F to about 120F, al-; though the mold temperature is not a particularly critical value.
The cycle is initiated as mold 38 is closed. The hy-draulic cylinder 44 thereupon moves the screw 22 forward toward mold 38. Screw 22 acts like a plunger and forces the mixed com-pound within barrel 20 toward the mold 38. The valve 42 opens and the heated mixed compound is thus forced into the mold cavity 40 into the configuration of a mask cushion.
At the end of the forward stroke of hydraulic cylinder 44 and screw 22, the shut-off valve 42 again closes and the screw 22 rotates to force additional mixed compound from the hopper 26 in the direction of the mold 38 within the barrcl 20. As the barrel 20 fills with mixed compound, the screw 22 rotates itself backwards and causes an internal backpressure on the mixed com-pound as the screw 22 moves back to its original position. The controlled backpressure exerted by the screw 22 on the mixed com-pound serves to pack the compound tightly and also serves to pre-vent the escaE)e of gas that is being released from the blowing agent backward toward hopper 26. At the end toward the mold 38, ~he valve 42 is, of course, now sllut so that no gas or plasti-cized material is lost or leaked into the mold 38.
As the mixed compound is compacted in the end of the barrel toward the mold 38, the compound passes through the heat-ing zones 28, 30, 32 and 34. As the mixed compound approaches the final heating zone 34, it becomes plasticized and the par-ticular blowing agent breaks down as a result of the pressure and temperature conditions and gives off a gas (in the case of the preferred blowing agent, that gas is nitrogen). The gas goes into solution with the plasticized material and remains in such form until the next injection step.
11~3Z~4 As the cycle is completed, the plasticized material that has been injected into the mold 38 cools, the mold 38 is opened and the thus formed mask cushion is removed.
The mold cavity 40 is vented to allow the escape of a predetermined amount of "freed" gas to achieve the desired mask cushion consistency. The amount of controlled venting determines the cellular size and therefore determines the pliability of the cushion. Too much venting results in coarse cell structure re-sulting in loss of pliability, while too little venting creates very fine, almost non-existent cell size, again resulting in an absence of pliability. The venting is determined by testing the particular mold cavity and setting and adjusting the amount of venting such that the desired cellular structure is achieved which exhibits soft pliable characteristics.
The resulting cushion 46 removed from the mold 38 is shown in Fig. 3. In the preferred form, the cushion 46 has a specific gravity of between about .5 to about .8 and with a base compound of 38 durometer (Shore A). The pliability exhibits adequate compressibility and is readily adapted to conform to the facial anatomical features of a patient.
The final patient mask 48, Fig. 4, is produced by af-fixing the foam cushion 46 to a cone 50. The cone 50 is formed by conventional methods, such as injection molding and is prefer-ably of a thermoplastic material such as PVC. The cone 50 may be opaque, transparent or translucent, depending upon the material used. Preferably the cone 50 is made of such a material 'PVC) such that the cone 50 may, if desired, be solvent bonded to the foam cushion 46. Alternatively, the cushion 46 and cone 50 may be affixed together by mechanical means or through bonding by means of a suitable adhesive, or by inserting the cone into the mold and molding the cushion to it ~insert molding).
g 11;~3Z14 Thus, there is produced a face mask having particular-ly advantageous softness characteristics by a judicious selec-tion of materials and conditions, such that a foam cushion is injection molded and which is affixed to a cone backing to pro-duce a face mask that is inexpensive to produce, yet which is easily adaptable to conform to the facial anatomical features of a patient. The cushion support is kept to a minimum through the cone backing and which allows its soft characteristic to be fully utilized in molding itself to the patient features with a minimum of pressure on the face mask, such as to reduce the pos-sibility of patient facial trauma.
It will be understood that the scope of the method and product of this invention is not limited to the particular steps or materials disclosed herein, by way of example, but only by the scope of the appended claims.
Claims (5)
1. A method for producing a patient face mask comprising the steps of:
a) combining and mixing uniformly together in a pre-determined ratio, polyvinyl chloride molding compound having a plasticizer and a blowing agent;
b) heating the combined mixed compound from step (a) to plasticize the compound and to cause the release of gas from the blowing agent;
c) injection molding the heated mixed compound into a mold having a cavity in the configuration of the desired mask cushion;
d) controlling the venting of mold during the injection step;
e) cooling the molded compound to cause solidification thereof;
f) removing the thus formed cushion from the mold; and g) affixing the cushion to a semi-rigid cone to produce a completed face mask.
a) combining and mixing uniformly together in a pre-determined ratio, polyvinyl chloride molding compound having a plasticizer and a blowing agent;
b) heating the combined mixed compound from step (a) to plasticize the compound and to cause the release of gas from the blowing agent;
c) injection molding the heated mixed compound into a mold having a cavity in the configuration of the desired mask cushion;
d) controlling the venting of mold during the injection step;
e) cooling the molded compound to cause solidification thereof;
f) removing the thus formed cushion from the mold; and g) affixing the cushion to a semi-rigid cone to produce a completed face mask.
2. A method as set forth in Claim 1 wherein said blow-agent used in step (a) is azodicarbonamide and is present in the resultant mixture in a range from about .25% to about 1.5% by weight
3. A method as set forth in Claim 2 wherein said heat-ing step takes place at a temperature in excess of about 300°F.
4. A method as set forth in Claim 1 wherein said affixing step comprises solvent bonding the cushion to a polyvinyl chloride cone.
5. A method set forth in Claim 1 wherein the cushion is insert molded to said cone.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97003978A | 1978-12-15 | 1978-12-15 | |
US970,039 | 1978-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1133214A true CA1133214A (en) | 1982-10-12 |
Family
ID=25516343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA340,865A Expired CA1133214A (en) | 1978-12-15 | 1979-11-29 | Disposable face mask |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU518083B2 (en) |
CA (1) | CA1133214A (en) |
ES (1) | ES486917A1 (en) |
FR (1) | FR2443918A1 (en) |
GB (1) | GB2038703B (en) |
ZA (1) | ZA796399B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8603558D0 (en) * | 1986-02-13 | 1986-03-19 | Lifeline Ltd | Face mask |
AU601483B2 (en) * | 1986-09-19 | 1990-09-13 | Kabushiki Kaisha Kobayashi | Method of injection-molding foamed products |
CA2019533A1 (en) * | 1989-11-09 | 1991-05-09 | William H. Hollister | Face mask and face mask components |
US5785910A (en) * | 1993-04-30 | 1998-07-28 | Kabushiki Kaisha Komatsu Seisakusho | Method for manufacturing laminate-molded products and apparatus therefor |
GB0002805D0 (en) * | 2000-02-08 | 2000-03-29 | Smiths Industries Plc | Masks and their manufacture |
WO2003016018A1 (en) * | 2001-08-17 | 2003-02-27 | Intersurgical Limited | Anatomical mask |
US20030168063A1 (en) * | 2002-03-08 | 2003-09-11 | Gambone Anthony Joseph | Pressure face mask and nasal mask |
DE102005033650B4 (en) * | 2005-07-19 | 2017-06-14 | Resmed R&D Germany Gmbh | Respiratory mask device and method of making the same |
AU2012244359B2 (en) * | 2005-07-19 | 2013-09-19 | Resmed Limited | Respiratory Mask and Method for Manufacturing a Respiratory Mask |
CN106999690B (en) * | 2014-10-10 | 2020-12-01 | 瑞思迈私人有限公司 | Foam Cushioned Respiratory Equipment |
CN109774053B (en) * | 2019-03-07 | 2019-11-15 | 山西纳安健康科技有限公司 | A kind of facial mask system of processing and facial mask processing method |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2625155A (en) * | 1950-12-11 | 1953-01-13 | Arthur E Engelder | Face mask |
GB920216A (en) * | 1959-08-27 | 1963-03-06 | Eileen Mary Catterall | Improvements in face masks for administering oxygen or other gases |
FR1576082A (en) * | 1961-07-12 | 1969-07-25 | ||
DE6933867U (en) * | 1969-08-28 | 1970-06-11 | Huels Chemische Werke Ag | INJECTION MOLD FOR THERMOPLASTICS CONTAINING DRYING AGENTS |
CH512987A (en) * | 1969-09-04 | 1971-09-30 | Buehler Ag Geb | Method and device for the injection molding of plastic into foamed objects |
GB1360632A (en) * | 1972-01-06 | 1974-07-17 | Roberts Ltd S F | Face masks |
NL7314357A (en) * | 1972-10-24 | 1974-04-26 | ||
SE382388B (en) * | 1973-12-19 | 1976-02-02 | Gnosjoeplast Ab | BREATHING MASK, SPECIAL FOR ARTIFICIAL BREATHING |
-
1979
- 1979-11-22 AU AU53113/79A patent/AU518083B2/en not_active Ceased
- 1979-11-26 ZA ZA00796399A patent/ZA796399B/en unknown
- 1979-11-29 CA CA340,865A patent/CA1133214A/en not_active Expired
- 1979-12-13 FR FR7930639A patent/FR2443918A1/en active Granted
- 1979-12-14 GB GB7943261A patent/GB2038703B/en not_active Expired
- 1979-12-14 ES ES486917A patent/ES486917A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU5311379A (en) | 1980-06-19 |
GB2038703B (en) | 1983-02-09 |
ES486917A1 (en) | 1980-06-16 |
FR2443918A1 (en) | 1980-07-11 |
FR2443918B1 (en) | 1983-08-26 |
ZA796399B (en) | 1980-11-26 |
AU518083B2 (en) | 1981-09-10 |
GB2038703A (en) | 1980-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1133214A (en) | Disposable face mask | |
CN1031122C (en) | Preparation method of ethylene-vinyl acetate copolymer foam shoe midsole | |
EP0485639B1 (en) | EVA insole manufacturing process | |
US4388358A (en) | Adaptive support system | |
CA2053194A1 (en) | Method for producing polypropylene resin article having skin material lined with foamed layer | |
ES439232A1 (en) | Process for producing molded structural foam article having a surface that reproducibly and faithfully replicates the surface of the mold | |
MXPA03002688A (en) | Extruded monolithic foam earplug. | |
US6026595A (en) | Method of making form fitted products | |
US5700407A (en) | Molded polymeric foam preparation method | |
US3880970A (en) | Process for producing microcellular shaped pieces of dimensional accuracy, particularly shoe soles | |
JPH1157090A (en) | Grip for golf club | |
KR19990022862A (en) | How to prepare a solid elastomer gel | |
GR3021008T3 (en) | Vandal-resistant seat. | |
GB2014168A (en) | Method of densifying open-celled polyurethane material | |
JP2734932B2 (en) | Fitting material for ski boots | |
US4937023A (en) | Method for manufacturing masks for fancy dresses or the like | |
EP1555285B1 (en) | Production method for a cosmetic applicator | |
JPS57150554A (en) | Injection molding with screw and its manufacture | |
JPH0822584B2 (en) | Method for manufacturing makeup puff | |
JPS564998A (en) | Manufacture of edge for speaker diaphragm | |
KR20030006219A (en) | Pillow Product Methode | |
JPS56146735A (en) | Manufacture of heat-insulating case | |
JPH08214913A (en) | Manufacture of foamed sole made of thermoplastic synthetic resin | |
Brands et al. | Developments in Structural Foam | |
DE59503043D1 (en) | Process for producing a molded body from at least two plastic foams of different densities and mold for carrying it out |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |